These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 17634419)

  • 1. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.
    Louhichi N; Triki C; Quijano-Roy S; Richard P; Makri S; Méziou M; Estournet B; Mrad S; Romero NB; Ayadi H; Guicheney P; Fakhfakh F
    Neurogenetics; 2004 Feb; 5(1):27-34. PubMed ID: 14652796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
    Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
    Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations.
    Hafner P; Bonati U; Fischmann A; Schneider J; Frank S; Morris-Rosendahl DJ; Dumea A; Heinimann K; Fischer D
    Neuromuscul Disord; 2014 Apr; 24(4):321-4. PubMed ID: 24556424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
    van Reeuwijk J; Maugenre S; van den Elzen C; Verrips A; Bertini E; Muntoni F; Merlini L; Scheffer H; Brunner HG; Guicheney P; van Bokhoven H
    Hum Mutat; 2006 May; 27(5):453-9. PubMed ID: 16575835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular heterogeneity in fetal forms of type II lissencephaly.
    Bouchet C; Gonzales M; Vuillaumier-Barrot S; Devisme L; Lebizec C; Alanio E; Bazin A; Bessières-Grattagliano B; Bigi N; Blanchet P; Bonneau D; Bonnières M; Carles D; Delahaye S; Fallet-Bianco C; Figarella-Branger D; Gaillard D; Gasser B; Guimiot F; Joubert M; Laurent N; Liprandi A; Loget P; Marcorelles P; Martinovic J; Menez F; Patrier S; Pelluard-Nehmé F; Perez MJ; Rouleau-Dubois C; Triau S; Laquerrière A; Encha-Razavi F; Seta N
    Hum Mutat; 2007 Oct; 28(10):1020-7. PubMed ID: 17559086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene.
    Balci B; Uyanik G; Dincer P; Gross C; Willer T; Talim B; Haliloglu G; Kale G; Hehr U; Winkler J; Topaloğlu H
    Neuromuscul Disord; 2005 Apr; 15(4):271-5. PubMed ID: 15792865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy.
    Yoshioka M
    Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.
    Messina S; Mora M; Pegoraro E; Pini A; Mongini T; D'Amico A; Pane M; Aiello C; Bruno C; Biancheri R; Berardinelli A; Boito C; Farina L; Morandi L; Moroni I; Pezzani R; Pichiecchio A; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Santorelli FM; Bertini E; Mercuri E
    Neuromuscul Disord; 2008 Jul; 18(7):565-71. PubMed ID: 18513969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain MRI abnormalities in muscular dystrophy due to FKRP mutations.
    Quijano-Roy S; Martí-Carrera I; Makri S; Mayer M; Maugenre S; Richard P; Berard C; Viollet L; Leheup B; Guicheney P; Pinard JM; Estournet B; Carlier RY
    Brain Dev; 2006 May; 28(4):232-42. PubMed ID: 16368217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Walker-Warburg syndrome resulting from a homozygous POMT1 mutation.
    Yis U; Uyanik G; Kurul S; Dirik E; Ozer E; Gross C; Hehr U
    Eur J Paediatr Neurol; 2007 Jan; 11(1):46-9. PubMed ID: 17161965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.
    Al-Zaidy SA; Baskin B; Hawkins C; Yoon G; Ray PN; Vajsar J
    Muscle Nerve; 2012 May; 45(5):752-5. PubMed ID: 22499106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
    Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
    Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.